Follow
Daniel SW Tan
Title
Cited by
Cited by
Year
Ceritinib in ALK-rearranged non–small-cell lung cancer
AT Shaw, DW Kim, R Mehra, DSW Tan, E Felip, LQM Chow, DR Camidge, ...
N Engl j med 370, 1189-1197, 2014
17062014
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
JC Soria, DSW Tan, R Chiari, YL Wu, L Paz-Ares, J Wolf, SL Geater, ...
The Lancet 389 (10072), 917-929, 2017
9842017
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Y Simoni, E Becht, M Fehlings, CY Loh, SL Koo, KWW Teng, JPS Yeong, ...
Nature 557 (7706), 575-579, 2018
8172018
Isolation and retrieval of circulating tumor cells using centrifugal forces
HW Hou, ME Warkiani, BL Khoo, ZR Li, RA Soo, DSW Tan, WT Lim, J Han, ...
Scientific reports 3 (1), 1259, 2013
7872013
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
KP Ng, AM Hillmer, CTH Chuah, WC Juan, TK Ko, ASM Teo, ...
Nature medicine 18 (4), 521-528, 2012
6222012
Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells
ME Warkiani, G Guan, KB Luan, WC Lee, AAS Bhagat, PK Chaudhuri, ...
Lab on a Chip 14 (1), 128-137, 2014
5672014
Liquid biopsy for advanced non-small cell lung cancer (NSCLC): a statement paper from the IASLC
C Rolfo, PC Mack, GV Scagliotti, P Baas, F Barlesi, TG Bivona, RS Herbst, ...
Journal of thoracic oncology 13 (9), 1248-1268, 2018
5022018
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial
DW Kim, R Mehra, DSW Tan, E Felip, LQM Chow, DR Camidge, ...
The lancet oncology 17 (4), 452-463, 2016
4522016
Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer
J Wolf, T Seto, JY Han, N Reguart, EB Garon, HJM Groen, DSW Tan, ...
New England Journal of Medicine 383 (10), 944-957, 2020
4302020
Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer
A Drilon, GR Oxnard, DSW Tan, HHF Loong, M Johnson, J Gainor, ...
New England Journal of Medicine 383 (9), 813-824, 2020
4202020
Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency
Y Simoni, M Fehlings, HN Kl°verpris, N McGovern, SL Koo, CY Loh, ...
Immunity 46 (1), 148-161, 2017
3902017
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
LJ Wirth, E Sherman, B Robinson, B Solomon, H Kang, J Lorch, F Worden, ...
New England Journal of Medicine 383 (9), 825-835, 2020
3682020
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials
A Drilon, S Siena, R Dziadziuszko, F Barlesi, MG Krebs, AT Shaw, ...
The Lancet Oncology 21 (2), 261-270, 2020
2922020
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes
A Drilon, ZI Hu, GGY Lai, DSW Tan
Nature reviews Clinical oncology 15 (3), 151-167, 2018
2682018
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
G Curigliano, S Banerjee, A Cervantes, MC Garassino, P Garrido, ...
Annals of Oncology 31 (10), 1320-1335, 2020
2332020
Phase Ib/II study of capmatinib (INC280) plus gefitinib after failure of epidermal growth factor receptor (EGFR) inhibitor therapy in patients with EGFR-mutated, MET factorá…
YL Wu, L Zhang, DW Kim, X Liu, DH Lee, JCH Yang, MJ Ahn, ...
Journal of Clinical Oncology 36 (31), 3101-+, 2018
2232018
Concurrent chemo-radiation with or without induction gemcitabine, carboplatin, and paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma
T Tan, WT Lim, KW Fong, SL Cheah, YL Soong, MK Ang, QS Ng, D Tan, ...
International Journal of Radiation Oncology* Biology* Physics 91 (5), 952-960, 2015
2212015
Biomarker-driven early clinical trials in oncology: a paradigm shift in drug development
DSW Tan, GV Thomas, MD Garrett, U Banerji, JS De Bono, SB Kaye, ...
The Cancer Journal 15 (5), 406-420, 2009
2022009
The international association for the study of lung cancer consensus statement on optimizing management of EGFR Mutation–Positive Non–Small cell lung cancer: Status in 2016
DSW Tan, SS Yom, MS Tsao, HI Pass, K Kelly, N Peled, RC Yung, ...
Journal of Thoracic Oncology 11 (7), 946-963, 2016
2002016
Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the headá…
NG Iyer, DSW Tan, VKM Tan, W Wang, J Hwang, NC Tan, R Sivanandan, ...
Cancer 121 (10), 1599-1607, 2015
1912015
The system can't perform the operation now. Try again later.
Articles 1–20